"The findings of late-phase trials found that the drug, called ocrelizumab, greatly reduced symptoms for progressive multiple sclerosis as well as a more common form of the disease, known as relapsing and remitting multiple sclerosis, which strikes about 85 percent of MS patients.7
source: http://ift.tt/1LFeLD0
source: http://ift.tt/1LFeLD0
promising new drug for treating MS
0 commentaires:
Enregistrer un commentaire